{
    "clinical_study": {
        "@rank": "143096", 
        "acronym": "VITJUNIOR", 
        "arm_group": [
            {
                "arm_group_label": "Vitafos Junior", 
                "arm_group_type": "Experimental", 
                "description": "Symbiotic Formula with DHA and antioxidants"
            }, 
            {
                "arm_group_label": "Standard Formula", 
                "arm_group_type": "Active Comparator", 
                "description": "Standard isocaloric and isonitrogenous formula."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether a nutritional supplement is effective in\n      the treatment of malnutrition in pediatric patients with failure to thrive or cystic\n      fibrosis."
        }, 
        "brief_title": "Clinical Study With an Enteral Formula With Symbiotic and DHA for Malnourished Children", 
        "completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Cystic Fibrosis", 
            "Failure to Thrive", 
            "Malnutrition"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Cystic Fibrosis", 
                "Failure to Thrive", 
                "Fibrosis", 
                "Malnutrition"
            ]
        }, 
        "detailed_description": {
            "textblock": "This is a multicenter, controlled, randomized, prospective, parallel-group, double-blind\n      study to evaluate the effect of a nutritional supplement on nutritional status in children\n      with failure to thrive or cystic fibrosis. Patients will be randomized to receive either a\n      symbiotic formula with DHA and antioxidants or a standard formula."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Malnutrition (P / T <-1 SD) by intake deficit without organic disease (failure to\n             thrive) and / or patients diagnosed with Cystic Fibrosis).\n\n          -  Age >= 1 year.\n\n          -  Stable patients\n\n          -  No antibiotherapy in the last 30 days\n\n          -  Inform consent signed (parent/legal representative)\n\n        Exclusion Criteria:\n\n          -  Patients with allergy / intolerance to cow's milk proteins\n\n          -  Metabolically unstable patient\n\n          -  Patients with metabolic intolerance to carbohydrates\n\n          -  Patients with severe disease in the last 30 days"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "1 Year"
        }, 
        "enrollment": {
            "#text": "130", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 28, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02128984", 
            "org_study_id": "VIT-2572-011"
        }, 
        "intervention": [
            {
                "arm_group_label": "Vitafos Junior", 
                "description": "6 months intervention.", 
                "intervention_name": "Symbiotic Formula with DHA and antioxidants", 
                "intervention_type": "Dietary Supplement", 
                "other_name": "Vitafos Junior"
            }, 
            {
                "arm_group_label": "Standard Formula", 
                "description": "6 months intervention.", 
                "intervention_name": "Standard Formula", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Antioxidants"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Malnutrition", 
            "Dietary supplement", 
            "Nutritional supplement", 
            "Symbiotic formula", 
            "DHA", 
            "Cystic Fibrosis", 
            "Failure to Thrive"
        ], 
        "lastchanged_date": "April 30, 2014", 
        "location": [
            {
                "contact": {
                    "email": "juan.riveramedina@gmail.com", 
                    "last_name": "Juan Rivera Medina, Doctor", 
                    "phone": "00051 994615917"
                }, 
                "facility": {
                    "address": {
                        "city": "Lima", 
                        "country": "Peru", 
                        "state": "Bre\u00f1a"
                    }, 
                    "name": "Instituto Nacional de Salud del Ni\u00f1o"
                }, 
                "investigator": {
                    "last_name": "Juan Rivera Medina, Doctor", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Coslada", 
                        "country": "Spain", 
                        "state": "Madrid", 
                        "zip": "28822"
                    }, 
                    "name": "Hospital de Henares"
                }, 
                "status": "Completed"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cartagena", 
                        "country": "Spain", 
                        "state": "Murcia", 
                        "zip": "30202"
                    }, 
                    "name": "Hospital Universitario Santa Luc\u00eda"
                }, 
                "status": "Completed"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Almer\u00eda", 
                        "country": "Spain", 
                        "zip": "04009"
                    }, 
                    "name": "Hospital de Torrec\u00e1rdenas"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "C\u00e1diz", 
                        "country": "Spain", 
                        "zip": "11009"
                    }, 
                    "name": "Hospital Puerta del Mar"
                }, 
                "status": "Completed"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28046"
                    }, 
                    "name": "Hospital Universitario La Paz"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sevilla", 
                        "country": "Spain", 
                        "zip": "41009"
                    }, 
                    "name": "Hospital Virgen Macarena"
                }, 
                "status": "Completed"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Zaragoza", 
                        "country": "Spain", 
                        "zip": "50009"
                    }, 
                    "name": "Hospital Universitario Miguel Servet"
                }, 
                "status": "Active, not recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "Peru", 
                "Spain"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "Clinical Study With an Enteral Formula With Symbiotic and DHA for Malnourished Children", 
        "other_outcome": {
            "description": "Tolerability to the formula in both groups", 
            "measure": "Tolerability", 
            "safety_issue": "No", 
            "time_frame": "At 1st, 3rd and 6th months"
        }, 
        "overall_contact": {
            "email": "maquedalama@gmail.com", 
            "last_name": "Rosa Lama, Doctor", 
            "phone": "678607358"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Spain: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Differences in faecal calprotectin's levels after 3rd and 6th months of treatment.", 
            "measure": "Changes in inflammatory response", 
            "safety_issue": "No", 
            "time_frame": "At 3rd and 6th months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02128984"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Differences measured by changes in weight, height, growth Z-scores, fat body mass and lean body mass.", 
                "measure": "Changes in nutritional status", 
                "safety_issue": "No", 
                "time_frame": "At 3rd and 6th months"
            }, 
            {
                "description": "Differences measured by changes in faecal microbiota composition.", 
                "measure": "Changes in microbiota profile", 
                "safety_issue": "No", 
                "time_frame": "At 3rd and 6th months"
            }, 
            {
                "description": "Differences in faecal interleukin levels. Only for cystic fibrosis patients.", 
                "measure": "Changes in Interleukin levels", 
                "safety_issue": "No", 
                "time_frame": "At 6th month"
            }, 
            {
                "description": "Episodes of infections during the study period", 
                "measure": "Incidence of Infections", 
                "safety_issue": "No", 
                "time_frame": "At 1st, 3rd and 6th months"
            }
        ], 
        "source": "Laboratorios Ordesa", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Quantum Experimental", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Peruvian Clinical Research", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Laboratorios Ordesa", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}